and firmly established mold fermentation as the method of choice in mass-production of penicillin.
DISCOVERY OF PENICILLIN
The penicillin story began in 1928, when a stray spore of greenish mold, later identified as Penicillium notatum, found its way onto a Petri dish that Alexander Fleming had seeded with a culture of Staphylococcus, a pathogenic bacterium. Fleming was a bacteriologist working at St. Mary's Hospital in London. In a moist environment, this common mold grows on anything from strawberry jam to shoe leather. 5 Later, while examining his plates prior to discarding them, Fleming noticed that bacteria adjacent to the mold were dead. He published several papers describing the antibiotic effect of penicillin in vitro using chemically undefined mold filtrate. Fleming never produced any extracted penicillin and made no extensive clinical tests. 6 Twelve years later, in 1940, Howard W. Florey, Ernst Chain, and Norman G. Heatley performed the first successful clinical tests of penicillin, after producing small quantities of the antibiotic from surface cultures and developing a method for measuring the amount extracted. 7 Florey's group began work on antibiotic substances in 1936, when he received a Rockefeller Foundation grant of 250 British pounds for the purchase of equipment.
8 Spectacular results were obtained when penicillin was used 5 . For a general perspective on mycology and the Penicillium molds, see Constantine J. Alexopoulos, Introductory Mycology (New York: John Wiley & Sons, Inc., 1962). More focused reviews are found in Charles Thorn, "Molds, mutants and monographers," Mycologia, 1952, 44, 61-85, and idem, "Mycology presents penicillin," Mycologia, 1945,37, 46o~75-In the dairy industry, Penicillium roaueforti and Penicillium camemberti are used to flavor Roquefort and Camembert cheeses. Danish blue and Italian Gorgonzola are also ripened using Penicillium molds. While several species of Penicillium molds produce penicillin, the two most prominent sources are Penicillium notatum and Penicillium chrysogenum. to treat mice infected with a virulent strain of streptococci. In 1941, their first clinical tests with human patients were also successful. 9 In 1941, after unsuccessfully attempting to interest a beleaguered British pharmaceutical industry in penicillin production, Florey and Heatley traveled to the U. S., where they hoped to interest American pharmaceutical companies in producing enough penicillin to continue their clinical tests. 10 The scientists began their quest in Washington, D.C., where they met with Ross G. Harrison, chairman of the National Research Council (NRC), Charles Thorn of the USDA's Bureau of Plant Industry and principal microbiologist of the USDA, and Percy Wells, head of the Eastern Regional Research Laboratory (ERRL).
After hearing Florey's description of the British production problem, Thorn and Wells immediately suggested that he visit the NRRL, where an elite team of fermentation specialists was already developing commercial-scale mold fermentation as a means of utilizing surplus farming produce. Wells contacted NRRL Director, Orville May, and arranged for a visit by the British scientists. On 14 July 1941 Florey and Heatley traveled to Peoria where they met with the staff to discuss penicillin production. Florey and Heatley could not have asked for a group better prepared to address the problem of producing large quantities of penicillin via fermentation.
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USDA FERMENTATION RESEARCH
The USDA had a long history of research and development of mold fermentation methods. Their work began in 1916, when Charles Thorn initiated a research program at the Bureau of Chemistry's microbiological laboratory. The laboratory's primary responsibility was to help enforce the Pure Food and Drugs Act, but, in the course of the work, Thorn collected a large number of Aspergillus and Penicillium molds. Together, Thorn and James N. Currie, a dairy chemist from the Bureau of Animal Industry, recorded the oxalic acid production capability of these fungi. They later noticed that strains of Aspergillus nigerwere capable of producing both oxalic and citric acid.
12 Soon afterwards, Currie left the lab and 9. Accounts of Florey's work are Macfarlane, (n. 6) Florey, Williams, (n. 6) Florey, Bickel, (n. 6) Rise Up To Life. For information on Ernst Chain, see Clark, (n. 6) Chain.
10. For a description of British penicillin production, see Jonathan Liebenau, "The British success with penicillin," Soc. Studies Set., 1987, 17, 69-86 . Despite the opportunity for a head start, British manufacturers were never able to reach the wartime production scale achieved by U. S. manufacturers.
11. Florey to W. Weaver, ujuly 1941, RAC, Record Group RF 1.1, Box 37, Folder 481. 12. James N. Currie, "The citric acid fermentation of Aspergillus Niger," J. Biol. Chem., 1917, continued his research with Charles Pfizer and Co., Inc. At Pfizer, he helped develop methods for mass-producing gluconic acid using mold fermentation. By 1923, they were the country's largest producer. Ultimately, dime's research and Pfizer's experience with large-scale fermentation, helped the company become the world's largest producer of penicillin during WW II.
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During the 1930s, a second generation of USDA scientists continued research on fermentation at the Bureau of Chemistry and Soil's Color Laboratory on the Arlington Experimental Farm in Arlington, VA (near the present site of the Pentagon). The Color Lab was built during WW I to support research on replacements for German dyes that were no longer available due to the wartime embargo. Horace T. Herrick, the laboratory director, assembled an outstanding research group at Arlington Farm. From 1930 to 1939, chemists Orville May (future NRRL director), Percy Wells (future ERRL director), and George Ward worked exclusively on mold fermentation. They were joined by Andrew J. Moyer, a mycologist, who focused primarily on growth media ( Figure   I )-In May 193 5, the group patented a "submerged" fermentation process in which a mold was grown throughout the medium. This method was a vast improvement over surface culture in which mold was grown in shallow pans. Their method was identical to that eventually used for mass production of penicillin. In this area, they were aided by R. Hellbach, the laboratory's instrument maker, who designed and built rotary fermenters using high purity aluminum which did not interfere with gluconic acid fermentation. Most importantly, Hellbach's cylinders were specially modified to permit scientists to control aeration, agitation, and temperature. Inner walls of the cylinders were lined with special "buckets and baffles which imparted violent mixing and exposure of the mass to the gaseous atmosphere." Using this apparatus, the Arlington group was able to determine the optimum conditions for submerged fermentation. Following their success with Hellbach's laboratory-scale cylinders, the USDA team built an aluminum fermenter with a capacity of 140 gallons. In 1936, this scaled-up fermenter was installed at the J'. 15-3 7-Oxalic acid is used for cleaning, bleaching, and dyeing. Citric acid is used to flavor foods, beverages, and pharmaceuticals.
13. George E. Ward, "Some contributions of the US Department of Agriculture to the fermentation industry," Adv. Appl. Miavbiol., 1970, 13, 363-82. According to Ward, in 1970, die total U.S. consumption of citric acid was about 125 million pounds, all of it produced via fermentation. By-Products Laboratory in Ames, Iowa (Figure 2 ). In 1938, Hellbach's fermenters were moved to the NRRL in Peoria, Illinois, where they were used to test submerged growth of Penicillium strains.
14 Andrew Moyer's objective was to develop effective media for growing molds in submerged culture. His most significant discovery came in r 937» when he began using corn steep liquor, a byproduct of the wet com milling industry (the corn-starch conversion process) as a component in growth medium. 15 Corn steep liquor later became the major component of all Penicillium growth media. With the exception of Percy Wells, who directed the Eastern Regional Research Laboratory (ERRL) during WW II, the group at Arlington Farms formed the nucleus of Robert Coghill's NRRL fermentation research group. Members of the Arlington Farm team who moved to the NRRL included O. E. May (director), George Ward, and Andrew J. Moyer. Needless to say, Florey could not have asked for a group better prepared to address the problem of growing Penicillium. As a sure sign of Florey's confidence in the USDA scientists, Norman Heatley remained in Peoria, sharing his knowledge of the Oxford Group's penicillin production and assay techniques.
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THE NORTHERN REGIONAL RESEARCH LABORATORY
Coghill's fermentation group approached the problem of penicillin production from three directions. Their first priority was to determine the nutritional requirements of Penicillium notatum growing in surface cultures. Secondly, they sought to develop a more efficient "submerged" culture process, where mold was grown throughout the media, rather than just on the surface. Lastly, they began testing other molds in the Penitillium group, in hopes of finding a more productive strain.
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Much of the NRRL's success was due to Coghill's outstanding organizational skills. Before working at the USDA laboratory, he was a chemistry professor at Yale University. At Yale he met Frank Stodola, a talented organic chemist working on the tuberculin bacillus. Coghill remembered Stodola's skills and, in 1942, he persuaded him to join the NRRL team at Peoria. He also recruited Jack Wachtel, a Yale-trained chromatography expert. Stodola and Wachtel were responsible for purifying penicillin.
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George Ward was charged with the task of designing and building the vats, fermenters, and aerated tanks necessary for pilot-scale production. Andrew Moyer worked on developing improved media for mold growth. Another significant member of Coghill's group was Kenneth Raper, a Harvard-educated mycologist, and a pupil of Charles Thorn. Raper brought Thorn's extensive collection of molds to the NRRL and led the successful effort to find more productive strains of Penicillium.
The first task addressed by the NRRL was to develop a better medium for Penicillium. Moyer had spent his career "feeding" molds and was immediately placed in charge of the project. His mycological work began in 1929, when he received his doctorate for a study of fungal growth responses to boron, manganese, and zinc. In 1936, Moyer, O. E. May, and H. T. Herrick published a paper describing the production of gluconic acid by Penicillium chrysogenum. 19 May remembered his talents and remarked that "if this problem of penicillin production can be solved, Dr. Moyer is the man to do it." 20 Moyer's first step in developing a Penicillium medium was to discontinue use of the Oxford groups's brewer's yeast extract as this material was not available in large quantities. Drawing upon his previous experience, Moyer suggested an entirely different medium composed primarily of corn steep liquor. Not unexpectedly, large quantities of liquor were available in Peoria, located in the middle of the U.S. corn belt. Moyer's medium proved to be the first major breakthrough and led to a thirty-fold increase in penicillin production. 21 Results with the new medium proved to be frustrating at first, leading Moyer to comment that "I kind of figure we're going to be doing some plain and fancy cussing around here." 22 Heatley described Moyer as a good but unorthodox research partner. They were able to work together despite Moyer's anti-British (isolationist) attitude and unwillingness to share details of his work. Moyer considered the use of corn steep medium to be his idea and was apparently very worried about losing credit for the discovery. He later remarked that "newspaper publicity, pictures, etc., as have been given me, have been of such nature that the true picture of my contribution to penicillin production is obscured.
>>23 According to Stodola, Moyer's upbringing may have contributed to his paranoia. His father deserted the family when he was five years old, and he was shuttled between relatives for much of his childhood. His unstable upbringing left him a bitter man who "wasn't going to let anybody beat him on anything." 24 Moyer is reputed to have published a paper in his name alone, which later enabled him to obtain foreign patents on the medium without consulting Headey or sharing the profits. Despite the claims of several historians, Heatley has never seen a published version of the paper which he and Moyer worked on at Peoria. 25 If Moyer did publish this paper, it is not included in his personal bibliography, nor is it listed as a basis for any of his patent applications. 26 In fact, Moyer had an aversion to writing 21. Com steep Liquor is produced by soaking individual kernels of com in large vats until the outer husks soften. The resulting liquid is rich in nutrients and provides an ideal medium for growing molds.
22. This perspective is found in a transcript of the NOVA television show: "Rise of a Wonder Drug," appearing on 18 March 1986 (NY: Journal Graphics, 1986). NOVA includes interviews with Coghill and Headey.
23. Andrew J. Moyer to Orville E. May, 24 June 1944, (n. 20). 24. Stodola interview, (n. 18). Moyer, Stodola, and odier members of die NRRL research group, were all avid golfers. On several occasions the group competed against each other at a course adjacent to the laboratory. Moyer was a good player, but, much to his chagrin, he was no match for Stodola, who financed his college education by working as a golf caddie.
25 26. Moyer's personal bibliography, (n. 20), contains no reference to an early paper on com steep medium, although he did acquire several patents related to penicillin production. Considering Moyer's reputation, it is highly unlikely that he would have omitted this supposed paper from his papers and generated very few during his tenure at the NRRL. In November 1943, NRRL director H. T. Herrick (replaced O. E. May as director), wrote Percy Wells that "we are endeavoring for the present to cut down on his laboratory work so as to give him the time to get at his notes." He also added that "from your experience with Dr. Moyer, I think you will understand how difficult it is to get him to write papers.
>>27
By law, Moyer could not obtain a U. S. patent for his work at the NRRL, but this did not prohibit him from seeking foreign patent rights.
28 Following the war, Moyer obtained a British patent and licensed it to Commercial Solvents Corporation, a major U. S. wartime penicillin producer. According to Coghill, Moyer's action was perfectly legal and proper, but it was "not very popular in England to be paying patent royalties on a British discovery. >>29 Heatley commented that "Moyer's patents could have been morally justifiable in that they concerned ideas, etc. which had certainly not been thought of at Oxford. ' )3°I n 1946, Moyer and Coghill filed for and received a joint patent on the addition of phenylacetic acid to the medium, a step which produced a sixty-six percent increase in yield of surface cultures. According to Coghill, Moyer could not license this new patent without the former's signature, which he refused to give. As a result, "Dr. Moyer never spoke to me again after that, and his wife wouldn't even speak to my wife."
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Moyer was also concerned that his contributions were never properly accounted for in descriptions of the penicillin project. According to Percy Wells, May arranged for the NRRL team to visit with President Roosevelt at the White House, but the meeting had to be scrapped due to the many letters of protest which Moyer was sending to congressmen complaining about his lack of recognition. could best be produced in shallow pans (surface culture) or in vats (submerged culture). As noted earlier, an alternative to surface culture was developed by the Color Laboratory group, which designed and built a special rotating pressure fermenter enabling scientists to experiment with submerged growth of the mold. Florey reported that, though initial yields of penicillins were low, "the fact that it was formed at all by a submerged growth was interesting, and suggests the possibility of using a vat type of fermenter." He concluded that, if successful, this method would simplify the production of the material on a large scale. Submerged fermentation methods were later adopted by all companies massproducing penicillin.
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In order to determine which strains of Penicillium were the most productive, thousands had to be screened. NRRL mycologist Kenneth R. Raper enlisted the aid of the Army Transport Command in gathering soil samples from all over the world. Of these, the most promising strains were isolated from soil collected in Chungking, Bombay, and Capetown. According to Coghill, "the travesty of this worldwide hunt was that the best producer of all was cultured from a moldy cantaloupe picked up in a Peoria fruit market."
34 The "cantaloupe strain" (NRRL 1951) is often believed to have been collected by Mary K. Hunt, a technician employed by Raper to visit nearby cheese factories and fruit stands in search of new strains. Raper later denied this "folklore," recalling that the melon came from a Peoria housewife who brought it to the laboratory. Furthermore, the cantaloupe was not locally grown and probably came from a market two to three days earlier. NRRL 1951 became the standard from which several more productive strains were subsequently derived. cant change from previous meetings, chief executive officers accompanied their research directors. The corporate chiefs assured Richards of their willingness to cooperate, but were very pessimistic about the possibility of mass-producing penicillin. George Merck reported that, even with his company's best fermentation and recovery yields, it was not humanly possible to produce even the kilo of penicillin that Florey wanted for clinical testing.
Immediately following Merck's speech, Coghill gave his report on research at the NRRL. The audience was stunned by the data showing yields of twenty-four units/ml in a simple medium containing corn steep liquor and lactose, using the improved mold strain, NRRL 1249-B21. Coghill later remarked that, as a result of the NRRL report, a new pharmaceutical industry was born. After listening to Coghill, Merck reversed his opinion and stated that, "if these results could be confirmed in their (Merck's) laboratories, it was possible to produce the kilo of material for Florey, and industry would do it!" 37 Richards' attempts to stimulate the necessary investment and overcome the barriers of risk and secrecy resulted in increased corporate enthusiasm. However, despite the success at NRRL, he was hesitant to devote CMR funds toward scaling up research at the laboratory. In October 194.1, Charles Thorn reported on the success at NRRL and urged the CMR to supply badly needed funds for additional equipment and personnel. As a result, Coghill received a grant of $8,250. An additional sum of $6,650 was granted in July 1943. By July 1944, NRRL had received a grand total of $30,700 from the CMR.
Clearly, NRRL and fermentation of Penicillium were of low priority to Richards, who remained convinced that synthesis was the key to mass production of penicillin. Financially, the CMR contributed little toward development of penicillin production via fermentation; their only financial support prior to 15 February 1942 was a grant of $8,250 to Coghill. 38 Despite the success of the NRRL, Richards also remained convinced that the key to mass production was held by large pharmaceutical companies the research directors from several large pharmaceutical manufacturers. Little was accomplished at this meeting other than to acquaint corporate leaders with the CMR's desire to expedite production. A second meeting on 17 November was also inconclusive. 39 In a January 1943 letter to Ferdinand Eberstadt of the WPB, Richards requested that Merck be given highpriority materials needed to expand penicillin production. He described Merck as "pioneers in this country in research which has supplied most of the existing information regarding feasible methods of growing the mold and extracting the substance." According to Richards, Merck's organization was capable of providing the supply, or a significant part of it, which "we foresee will soon be called for. ' >4°T he CMR focused most of its attention on clinical tests and the effort to synthesize penicillin. Clinical investigations were headed by Chester S. Keefer, who used OSRD funds to purchase $1,900,000 worth of penicillin from industry for use in testing. The primary objective of Keefer's group was to gather information on dosage, methods of administration, duration of treatment, and reactions. 41 Richards organized the unsuccessful attempt to produce synthetic penicillin, which involved contracts with sixteen commercial firms and two government agencies. 42 The government spent $350,000 on synthesis research at universities, while the five pharmaceutical firms, no doubt hoping that synthesis would give them the "leg up" on fermentation, expended $3,000,000. During the 1930s, Merck's researchers experienced great success in synthesizing B vitamins, a feat which George Merck was sure they could duplicate with penicillin. He committed $781,000 to the project and promised the OSRD a bottle of synthetic penicillin by New Year's Day of 1945. 43 However, despite the large expenditure of funds and man-power, the government-industry research program was unable to synthesize penicillin. In 1959, penicillin was finally synthesized byjohn Sheehan and K. R. Henery-Logan, but even in 1992, fermentation is still by far the most efficient method of production.
THE WAR PRODUCTION BOARD
Richards' efforts to bring government and industry together set the stage for an enormous joint effort. However, the vast amounts of money and materials necessary for mass production of penicillin could come from only one source, the War Production Board (WPB). Large-scale production of penicillin by fermentation began in May 1943, following the combined effort of the NRRL in developing mass production techniques and the successful clinical evaluations by the CMR. Chemical and drug producers, some of whom had already conducted their own research on penicillin, were eager to begin mass production, but needed WPB assistance in obtaining necessary materials and equipment. 45 In June 1943, the National Academy of Sciences helped organize the shift to mass production by hosting a meeting of government representatives. These included Richards and Keefer of the CMR, Elihu Root of the NAS, Major Purinton of the Army, and Coghill. The WPB's Chemical Division was represented by Fred Stock, William J. McManus, Roy S. Koch, and John N. McDonnell. Their discussion focused on priorities, allocation, and "whether to permit producers to operate on their own responsibility or to introduce Government interest directly into the matter."
46 Stock made it clear that, since research on penicillin had reached a production stage, it was time for the WPB to assist in expedition of the program. A beginning production goal of 200 billion units per month was set. This figure soon proved to be overly ambitious, as total production for the first five months was a mere 400 million units (4000 packages of 100,000 units).
The WPB's inability to meet initial production goals led to criticism from the Army Service Forces, which felt that a personality clash between Stock and McManus was hindering production. The Army was particularly concerned by the failure to employ a technically knowledgeable troubleshooter to coordinate the activities of companies manufacturing penicillin. Army representatives complained that we are "begging them 44 . J. C. Sheehan and K. R. Henery-Logan, "The total synthesis of Penicillin V," J. to get somebody and put them in charge," but "for five weeks they have been dickering about who it might be. " 47 These observations were relayed to WPB chief, Donald Nelson, who assigned blanket AA-i ratings for all materials and equipment needed to expedite the penicillin program, but shied away from appointing a penicillin czar. 48 On 22 September 1943, the first meeting of the WPB's Penicillin Producers Industry Advisory Committee was held in the Social Security Building in Washington. Their objective was to discuss functions of government agencies responsible for development of the penicillin program. These included policies and programs on clinical studies, chemical research, civilian distribution, dissemination of information on production, increasing production, production standards, and packaging. Responsibilities were divided amongst three government agencies. The CMR would handle clinical and chemical research, and deal with civilian requests for penicillin. The NRRL would continue its assay work on commercial production of penicillin, a task which would eventually be passed to the Food and Drug Administration. Lastly, the WPB's Chemical Division would handle selection of facilities to make penicillin, expand existing efforts, coordinate production and processes, and allocate penicillin and raw materials for its production. The most significant organizational change was the addition of a program coordinator. The WPB's new "penicillin czar" was Albert Elder, a chemist who was employed as the WPB's head chemical advisor from 1942 to 1943. Elder's involvement began when he was approached by James Raynolds, deputy director of the WPB's Chemicals Division, whom Elder described as "pacing his office and bemoaning the fact that tremendous pressure was being put on him to get the penicillin program moving. " 51 Elder had read about the new antibiotic and informed Raynolds that the solution to his problem was "better cultures, better media, better growing conditions, and better extraction conditions." 52 Shortly afterwards, he was named as Coordinator of the Penicillin Program. Elder worked closely with Fred Stock of the Chemical Division, who handled business and administrative aspects of the project. He was also assisted by the Army Service Forces, which assigned a group of officers to the project. In March 1943, Elder began his tenure as penicillin "czar" with a tour of all on-going penicillin production facilities.
Following the war, Elder recalled that the most important deterrent to the mass production of penicillin was the tremendous emphasis placed on the synthesis of penicillin by Richards and the CMR. Elder was "ridiculed by some of my closest scientific friends" for "allowing myself to become associated with what obviously was to be a flop-namely the commercial production of penicillin by a fermentation process." He credited the Army's "bird in the hand is worth two in the bush" attitude for ensuring continued production of penicillin by fermentation.
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Elder's concerns about the emphasis on synthesis were echoed in a 27 November 1943 progress report by James Biller, a WPB investigator, who conducted a survey of die thirteen major participants in the WPB program. After visiting Squibb, Biller remarked that, while a pilot plant was eighty percent complete, and a new plant was well along toward completion by the projected date of 15 December, the "Squibb people felt there might be a delay of 2 or 3 months beyond this date in order to prove their process." Biller described this delay as unreasonable and suggested that the WPB request an explanation. In his conclusion, Biller noted that the: Belief that synthesis of the drug may be imminent may be contributing to a lackadaisical attitude on the part of some producers who feel that it would be foolish to waste a lot of time and money on a relatively inefficient method of production when large scale production of a synthetic may be just around the comer. 54 Biller also commented on the high quality of equipment procured by the firms and the overly elaborate construction, which in some cases might delay projected operating dates. He was particularly concerned with Commercial Solvents' "steel frame masonry building with reinforced concrete floor and roof and in every detail equal to any industrial building built before Pearl Harbor." This building "makes one wonder whether they have heard a war is being fought" and shows no effort to conserve materials or manpower. 55 Biller's concern with construction was legitimate, as in retrospect the projected cost of many plants changed significantly and in some cases was approximately twice the original estimate. For example, the planned cost of the Commercial Solvents' plant was $441,700, but the final expenditure was $1,426, ioo. 56 Elder justified overspending by dividing the production capacity in billions of units per month into the capital cost of construction. Figures varied from "a few thousand dollars per billion units to approximately $300,000." Elder also cited the great speed with which engineers and contractors completed the task of building and equipping the penicillin production plants as further justification for the cost over-run.
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Assisted by the Army Service Forces, Elder minimized delay by obtaining in advance the necessary scientific control instruments, critical steel equipment, motors, filters, air-conditioning equipment, heat exchangers, centrifuges, sterilizers, vacuum pumps, drying ovens, and numerous other items needed for the production of penicillin. Captain A. B. Hatch was assigned to Elder's office with the task of following up on biological developments. 58 In October 1943, WPB Requirements Committee chairmanj. A. Krug reaffirmed the program's top preference rating (AA-i) for materials and equipment. The estimated total cost of the program was $13,983,110 for a projected 176.9 billion units of penicillin per month. The WPB interviewed or corresponded with 175 potential producers of penicillin, of which twenty were integrated into the new production program. Criteria for selection included: experience with penicillin, knowledge of chemical production by fermentation, general experience with biological products, the availability of trained technical staff and facilities. 60 Companies which met these qualifications were eligible to receive equipment from the WPB. Elder turned to the OPRD for help in overcoming the production "bottlenecks" which he had observed at penicillin production facilities.
THE OFFICE OF PRODUCTION RESEARCH AND DEVELOPMENT OPRD initiated penicillin research projects at the University of Wisconsin, University of Minnesota, Stanford University, and the Carnegie Institution's Cold Spring Harbor Laboratory. The overall objective of this research was to solve the technical problems that arose when laboratory production was scaled up to a commercial level. At Wisconsin, W. H. Peterson headed a research group of biochemists, bacteriologists, and botanists working on fermentation. At Minnesota, E. C. Stakman searched for more productive strains of Penicillium notatum, while, at Stanford, G. W. Beadle directed a group trying to make mutants which would yield more penicillin. At Cold Spring Harbor, M. Demerec also produced and screened penicillin mutants. 61 The OPRD facilitated the exchange of results between their various projects and with the NRRL. Elder was very concerned with progress of OPRD's research projects and considered their contributions along with those of the NRRL to be of critical value to producers. 62 WPB officials created a technical advisory group to transmit results from the OPRD projects to penicillin producers. Donald G. Keyes, chief of the WPB's Chemical Industries Branch, called for representatives from all penicillin manufacturers to form the advisory group with a WPB official as chairman. In January 1944, after attending the first meeting of industry representatives, Keyes commented that the "distribution of recent research findings from the OPRD projects was appreciated by the penicillin industry and was a real contribution to increased production. In his first report, Beadle informed OPRD that "we do not have any thoroughly verified super strains although as usual we have some promising ones coming up." Beadle was disappointed with the lack of correlation between surface and flask yields, which made it impractical to use surface culture results to estimate submerged production. The Stanford group was able to increase production using UV or X-ray treatment, but was unable to obtain a strain which performed consistently as either a surface or submerged producer. 73 By July 1944, Beadle's group had tested 15,000 strains and selected three which they thought might be useful for commercial production. These strains were sent to Peoria and Wisconsin for further testing. In an OPRD report, Beadle stated that while "retests have not yet been completed on all the promising strains . . . we have hopes that one or more of them will be the' 100% increase' we have been hoping for. " 74 The best producer was a derivative of NRRL 1951, which yielded 190 units of penicillin per ml. Monroe hoped that Beadle's group would eventually isolate an even more productive strain and extended their OPRD contract for four months, including one more month of spore irradiation and three months of review and retesting of promising strains. In order to increase the testing speed of the new Stanford strains, Monroe accepted the proposal of Howard M. Winegarden of Cutter Laboratories in Berkeley, California, who expressed great interest in the work at Stanford and offered to try out the most promising cultures, both in surface growths and in submerged cultures. 75 Writing to Beadle, Monroe encouraged him to take the offer, especially with regard to Stanford's strain 23248 (derivative of NRRL 1951) which Peoria had found to be particularly productive and worthy of early pilot plant testing. In August 1944, Stanford 1982 was the best strain tested at Wisconsin. Strain 23248 also had some excellent properties, yielding much better looking mycelium from the standpoint of filtration than NRRL 832 and NRRL 1951-B25. 77 Stanford cultures tested at Wisconsin showed increased productivity, but not the 100% increase which Demerec's group achieved at Cold Spring Harbor. L. A. Monroe was very pleased with Beadle's part in the OPRD research effort, noting that, while "It is difficult to evaluate the contribution of any one individual or a group to a manufacturing program, we can all certainly be sure that the Stanford group's contribution to the present highly satisfactory production of penicillin has been a very important one indeed. " 78 The Carnegie Institution's Cold Spring Harbor Laboratory was the first research group to isolate a "super" strain. Members of this research team were Milislav Demerec, Eva R. Sansome, and H. E. Warmke, all associated with the Department of Genetics. Demerec was among the first to realize that an increase in penicillin yields might be achieved by producing and screening mutants. In 1942, he began working independently on the problem with A. Hollaender of the National Institutes of Health (NIH). Demerec and Hollaender based their work on extensive experience with the irradiation of fungi and on Hollaender's work with Coghill in developing a strain of the black bread mold Aspergillus with a higher yield of itaconic acid. 79 On 15 October 1942, Demerec sent Bush a letter informing him that "for more than a year Dr. Hollaender and I had been considering the possibilities of utilizing modern genetic methods for improving the yield of various microorganisms used in the production of chemicals important in the war." Demerec also included a memorandum requesting funds to continue his research on mutations of Penicillium. Bush forwarded his request to Richards, who informed him on 21 December 1942 that "the speculative character of the whole penicillin project, and particularly this mutant aspect of it, ... deterred me from urging our committee to recommend a contract with the Carnegie Institution." In retrospect, Richards' lack of enthusiasm is remarkable considering he had just organized and attended (17 December) a highly successful meeting at which Coghill unveiled the NRRL's efficient method for mass production of penicillin via fermentation. His response may well be another indication that synthesis and not fermentation was Richards' preferred method of production. Though unwilling to give the Cold Spring Laboratory a contract, Richards did suggest that Hollaender "send irradiated cultures to Merck, who agreed to test 50 cultures per week." Hollaender followed Richards' suggestion, but was very disappointed with the results as "Merck showed a complete lack of interest in conducting the tests. ' >8°D espite the lack of government and corporate interest, Demerec reorganized his work on irradiation of fungi to include experimentation with Penicillium on a modest scale and continued his cooperative effort with Hollaender at NIH. In March 1944, he learned of the OPRD's interest in developing penicillin strains from W. M. Gilbert, Executive Officer of the Carnegie Institution of Washington. 81 Gilbert contacted L. A. Monroe of the OPRD and discussed the possibility of obtaining funding for Demerec's work. Gilbert also presented the proposal to Bush, whose comments provide some valuable insight into OSRD/CMR's rather non-committal approach to the fermentation project:
This looks, sounds, and appears to be worth doing. Synthesis may make all this work obsolete, but it may not, and the overall problem is so important that no leads should be neglected. If OPRD makes a definite request that we proceed, I feel we should do so. There is a bare possibility that mutant strains may yield a variant of penicillin of higher potency. This is a remote chance, but should not be overlooked. 82 Fortunately for penicillin producers, Demerec did receive an OPRD contract and proceeded to bombard the NRRL's cantaloupe strain (NRRL 1951-B25) with X-rays. The resulting penicillin strain (x-1612) was the first "super strain" to emerge from the OPRD project. Demerec's mutant strain increased penicillin production from 250 units per ml. to 500-600 units, more than doubling productivity. 83 Further testing of the most promising strains produced at Stanford, Cold Spring Harbor, and the University of Minnesota took place at Wisconsin. Here, Peterson's group collected data on fermentation time and yield from mutant strains. Tests were conducted in eighty-gallon tanks containing 220 liters of medium, 20 liters of which was inoculum grown in a smaller tank under aeration and agitation. Of all the cultures tested at Wisconsin, only Demerec's x-1612 gave a yield which was greatly in excess of that obtained from NRRL 1951-B25. M.J.Johnson, M. P. Backus, and J. F. Stauffer, members of the Wisconsin research team, irradiated spores from Demerec's super strain and, in June 1945, the group produced Wisconsin Q176, a mutant strain of x-1612 which was seventy-seven percent more productive. In tank tests, Wisconsin's new Q176 gave higher yields than any previous culture. 84 When, on 25 February 1944, Albert Elder resigned his position as coordinator of the Penicillin project, construction and installation of equipment in the twenty-one government-assisted plants was over ninety percent complete. Monthly production rates had increased from approximately 100 million units to 18,726 million units in February 1944. However, despite the vast production increase, the industry was still hampered by technical problems. Elder recommended that the services of the OPRD be used to the fullest extent in overcoming problems such as improved media, efficient recovery, higher speeds through centrifuges involving the breaking of emulsions, higher unitage material, stability of product, recovery of solvents and reuse of charcoal, and improved drying techniques. He was also particularly concerned with the continued exchange of technical information as "it is entirely possible that some one producer may make such a drastic improvement in the process that total needs for penicillin could be met very quickly by applying this information to all of the production facilities." 85 Three U.S. pharmaceutical companies, Pfizer, Squibb, and Merck were the most powerful corporations engaged in research, development, and production of penicillin. Elder's complaint about the lack of cooperation among penicillin producers was particularly evident in the case of the Big Three, who were often unwilling to share all in their research findings with government agencies. In October 1942, Coghill protested to Chester Keefer of the OSRD's Committee on Medical Research that the exchange of information was a one-way street: "As far as we are concerned here at Peoria, it has been largely a case of giving all our information and receiving very little." 86 Coghill also reported that Richards looked upon Merck, Squibb, Pfizer, and Lederle as something in the nature of a closed corporation to which others would be admitted only if they had something to contribute. 87 However, despite friction between government and industry, the techniques and productive Penicillium strains were made available to all corporations, resulting in the emergence of a revolutionary new antibiotics industry.
CONCLUSION
Government laboratories and research programs made an enormous contribution toward the development of penicillin during WW II. Robert Coghill's NRRL research group made by far the most significant advances toward mass production. Operating with limited funds and fighting the constant resistance of those advocating synthesis, this group of virtual unknowns helped bring about a medical revolution. The WPB's Chemical Division brought the NRRL discoveries to industry by funding factory construction and distributing technical information. The OPRD continued to refine Penicillium strains by coordinating research at universities and government laboratories. By 1944, the combined efforts of government and industry resulted in a production increase from 4 units per ml in 1941 to over 900 units per ml. 88 This transition, from laboratory, to pilot plant, and finally to mass production took place in an amazingly short period of time. The end result was an enormously successful post-war antibiotics industry. In many ways, this new industry was a product of the government's prominent role in directing pharmaceutical research, development, and production during WW II.
